The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medically Induced Coma Market Research Report 2025

Global Medically Induced Coma Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1679826

No of Pages : 92

Ask Your Query
Synopsis
Market Analysis and Insights: Global Medically Induced Coma Market
Medically induced coma is induced in patients with traumatic brain injury who need to cure infection. When doctors use certain drugs, they cause coma. This is an unconscious state in which the body does not feel pain. This is an effective stop of brain activity during trauma surgery.
The global Medically Induced Coma market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Propofol accounting for % of the Medically Induced Coma global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Medically Induced Coma market size is valued at US$ million in 2021, while the North America and Europe Medically Induced Coma are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medically Induced Coma landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medically Induced Coma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medically Induced Coma market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medically Induced Coma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medically Induced Coma market.
Global Medically Induced Coma Scope and Market Size
Medically Induced Coma market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Medically Induced Coma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Propofol
Barbiturate
Segment by Application
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astrazeneca
B. Braun Melsungen
Baxter Healthcare Corporation
Dr.Reddy's Laboratories
Fresenious
Hikma Pharmaceuticals
Pfizer
Piramal Healthcare
Teva Pharmaceuticals Industries
Viatris
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medically Induced Coma Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Propofol
1.2.3 Barbiturate
1.3 Market by Application
1.3.1 Global Medically Induced Coma Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores & Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medically Induced Coma Market Perspective (2017-2028)
2.2 Medically Induced Coma Growth Trends by Region
2.2.1 Medically Induced Coma Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Medically Induced Coma Historic Market Size by Region (2017-2022)
2.2.3 Medically Induced Coma Forecasted Market Size by Region (2023-2028)
2.3 Medically Induced Coma Market Dynamics
2.3.1 Medically Induced Coma Industry Trends
2.3.2 Medically Induced Coma Market Drivers
2.3.3 Medically Induced Coma Market Challenges
2.3.4 Medically Induced Coma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medically Induced Coma Players by Revenue
3.1.1 Global Top Medically Induced Coma Players by Revenue (2017-2022)
3.1.2 Global Medically Induced Coma Revenue Market Share by Players (2017-2022)
3.2 Global Medically Induced Coma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medically Induced Coma Revenue
3.4 Global Medically Induced Coma Market Concentration Ratio
3.4.1 Global Medically Induced Coma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medically Induced Coma Revenue in 2021
3.5 Medically Induced Coma Key Players Head office and Area Served
3.6 Key Players Medically Induced Coma Product Solution and Service
3.7 Date of Enter into Medically Induced Coma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medically Induced Coma Breakdown Data by Type
4.1 Global Medically Induced Coma Historic Market Size by Type (2017-2022)
4.2 Global Medically Induced Coma Forecasted Market Size by Type (2023-2028)
5 Medically Induced Coma Breakdown Data by Application
5.1 Global Medically Induced Coma Historic Market Size by Application (2017-2022)
5.2 Global Medically Induced Coma Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Medically Induced Coma Market Size (2017-2028)
6.2 North America Medically Induced Coma Market Size by Country (2017-2022)
6.3 North America Medically Induced Coma Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Medically Induced Coma Market Size (2017-2028)
7.2 Europe Medically Induced Coma Market Size by Country (2017-2022)
7.3 Europe Medically Induced Coma Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medically Induced Coma Market Size (2017-2028)
8.2 Asia-Pacific Medically Induced Coma Market Size by Country (2017-2022)
8.3 Asia-Pacific Medically Induced Coma Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Medically Induced Coma Market Size (2017-2028)
9.2 Latin America Medically Induced Coma Market Size by Country (2017-2022)
9.3 Latin America Medically Induced Coma Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medically Induced Coma Market Size (2017-2028)
10.2 Middle East & Africa Medically Induced Coma Market Size by Country (2017-2022)
10.3 Middle East & Africa Medically Induced Coma Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Detail
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Medically Induced Coma Introduction
11.1.4 Astrazeneca Revenue in Medically Induced Coma Business (2017-2022)
11.1.5 Astrazeneca Recent Development
11.2 B. Braun Melsungen
11.2.1 B. Braun Melsungen Company Detail
11.2.2 B. Braun Melsungen Business Overview
11.2.3 B. Braun Melsungen Medically Induced Coma Introduction
11.2.4 B. Braun Melsungen Revenue in Medically Induced Coma Business (2017-2022)
11.2.5 B. Braun Melsungen Recent Development
11.3 Baxter Healthcare Corporation
11.3.1 Baxter Healthcare Corporation Company Detail
11.3.2 Baxter Healthcare Corporation Business Overview
11.3.3 Baxter Healthcare Corporation Medically Induced Coma Introduction
11.3.4 Baxter Healthcare Corporation Revenue in Medically Induced Coma Business (2017-2022)
11.3.5 Baxter Healthcare Corporation Recent Development
11.4 Dr.Reddy's Laboratories
11.4.1 Dr.Reddy's Laboratories Company Detail
11.4.2 Dr.Reddy's Laboratories Business Overview
11.4.3 Dr.Reddy's Laboratories Medically Induced Coma Introduction
11.4.4 Dr.Reddy's Laboratories Revenue in Medically Induced Coma Business (2017-2022)
11.4.5 Dr.Reddy's Laboratories Recent Development
11.5 Fresenious
11.5.1 Fresenious Company Detail
11.5.2 Fresenious Business Overview
11.5.3 Fresenious Medically Induced Coma Introduction
11.5.4 Fresenious Revenue in Medically Induced Coma Business (2017-2022)
11.5.5 Fresenious Recent Development
11.6 Hikma Pharmaceuticals
11.6.1 Hikma Pharmaceuticals Company Detail
11.6.2 Hikma Pharmaceuticals Business Overview
11.6.3 Hikma Pharmaceuticals Medically Induced Coma Introduction
11.6.4 Hikma Pharmaceuticals Revenue in Medically Induced Coma Business (2017-2022)
11.6.5 Hikma Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Medically Induced Coma Introduction
11.7.4 Pfizer Revenue in Medically Induced Coma Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 Piramal Healthcare
11.8.1 Piramal Healthcare Company Detail
11.8.2 Piramal Healthcare Business Overview
11.8.3 Piramal Healthcare Medically Induced Coma Introduction
11.8.4 Piramal Healthcare Revenue in Medically Induced Coma Business (2017-2022)
11.8.5 Piramal Healthcare Recent Development
11.9 Teva Pharmaceuticals Industries
11.9.1 Teva Pharmaceuticals Industries Company Detail
11.9.2 Teva Pharmaceuticals Industries Business Overview
11.9.3 Teva Pharmaceuticals Industries Medically Induced Coma Introduction
11.9.4 Teva Pharmaceuticals Industries Revenue in Medically Induced Coma Business (2017-2022)
11.9.5 Teva Pharmaceuticals Industries Recent Development
11.10 Viatris
11.10.1 Viatris Company Detail
11.10.2 Viatris Business Overview
11.10.3 Viatris Medically Induced Coma Introduction
11.10.4 Viatris Revenue in Medically Induced Coma Business (2017-2022)
11.10.5 Viatris Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Medically Induced Coma Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Propofol
Table 3. Key Players of Barbiturate
Table 4. Global Medically Induced Coma Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Medically Induced Coma Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Medically Induced Coma Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Medically Induced Coma Market Share by Region (2017-2022)
Table 8. Global Medically Induced Coma Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Medically Induced Coma Market Share by Region (2023-2028)
Table 10. Medically Induced Coma Market Trends
Table 11. Medically Induced Coma Market Drivers
Table 12. Medically Induced Coma Market Challenges
Table 13. Medically Induced Coma Market Restraints
Table 14. Global Medically Induced Coma Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Medically Induced Coma Market Share by Players (2017-2022)
Table 16. Global Top Medically Induced Coma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medically Induced Coma as of 2021)
Table 17. Ranking of Global Top Medically Induced Coma Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Medically Induced Coma Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Medically Induced Coma Product Solution and Service
Table 21. Date of Enter into Medically Induced Coma Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medically Induced Coma Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Medically Induced Coma Revenue Market Share by Type (2017-2022)
Table 25. Global Medically Induced Coma Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Medically Induced Coma Revenue Market Share by Type (2023-2028)
Table 27. Global Medically Induced Coma Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Medically Induced Coma Revenue Market Share by Application (2017-2022)
Table 29. Global Medically Induced Coma Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Medically Induced Coma Revenue Market Share by Application (2023-2028)
Table 31. North America Medically Induced Coma Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Medically Induced Coma Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Medically Induced Coma Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Medically Induced Coma Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Medically Induced Coma Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Medically Induced Coma Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Medically Induced Coma Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Medically Induced Coma Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Medically Induced Coma Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Medically Induced Coma Market Size by Country (2023-2028) & (US$ Million)
Table 41. Astrazeneca Company Detail
Table 42. Astrazeneca Business Overview
Table 43. Astrazeneca Medically Induced Coma Product
Table 44. Astrazeneca Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 45. Astrazeneca Recent Development
Table 46. B. Braun Melsungen Company Detail
Table 47. B. Braun Melsungen Business Overview
Table 48. B. Braun Melsungen Medically Induced Coma Product
Table 49. B. Braun Melsungen Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 50. B. Braun Melsungen Recent Development
Table 51. Baxter Healthcare Corporation Company Detail
Table 52. Baxter Healthcare Corporation Business Overview
Table 53. Baxter Healthcare Corporation Medically Induced Coma Product
Table 54. Baxter Healthcare Corporation Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 55. Baxter Healthcare Corporation Recent Development
Table 56. Dr.Reddy's Laboratories Company Detail
Table 57. Dr.Reddy's Laboratories Business Overview
Table 58. Dr.Reddy's Laboratories Medically Induced Coma Product
Table 59. Dr.Reddy's Laboratories Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 60. Dr.Reddy's Laboratories Recent Development
Table 61. Fresenious Company Detail
Table 62. Fresenious Business Overview
Table 63. Fresenious Medically Induced Coma Product
Table 64. Fresenious Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 65. Fresenious Recent Development
Table 66. Hikma Pharmaceuticals Company Detail
Table 67. Hikma Pharmaceuticals Business Overview
Table 68. Hikma Pharmaceuticals Medically Induced Coma Product
Table 69. Hikma Pharmaceuticals Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 70. Hikma Pharmaceuticals Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Medically Induced Coma Product
Table 74. Pfizer Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Piramal Healthcare Company Detail
Table 77. Piramal Healthcare Business Overview
Table 78. Piramal Healthcare Medically Induced Coma Product
Table 79. Piramal Healthcare Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 80. Piramal Healthcare Recent Development
Table 81. Teva Pharmaceuticals Industries Company Detail
Table 82. Teva Pharmaceuticals Industries Business Overview
Table 83. Teva Pharmaceuticals Industries Medically Induced Coma Product
Table 84. Teva Pharmaceuticals Industries Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 85. Teva Pharmaceuticals Industries Recent Development
Table 86. Viatris Company Detail
Table 87. Viatris Business Overview
Table 88. Viatris Medically Induced Coma Product
Table 89. Viatris Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million)
Table 90. Viatris Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medically Induced Coma Market Share by Type: 2021 VS 2028
Figure 2. Propofol Features
Figure 3. Barbiturate Features
Figure 4. Global Medically Induced Coma Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Drug Stores & Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Medically Induced Coma Report Years Considered
Figure 9. Global Medically Induced Coma Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Medically Induced Coma Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Medically Induced Coma Market Share by Region: 2021 VS 2028
Figure 12. Global Medically Induced Coma Market Share by Players in 2021
Figure 13. Global Top Medically Induced Coma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medically Induced Coma as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Medically Induced Coma Revenue in 2021
Figure 15. North America Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Medically Induced Coma Market Share by Country (2017-2028)
Figure 17. United States Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Medically Induced Coma Market Share by Country (2017-2028)
Figure 21. Germany Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Medically Induced Coma Market Share by Region (2017-2028)
Figure 29. China Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Medically Induced Coma Market Share by Country (2017-2028)
Figure 37. Mexico Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Medically Induced Coma Market Share by Country (2017-2028)
Figure 41. Turkey Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Medically Induced Coma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Astrazeneca Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 44. B. Braun Melsungen Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 45. Baxter Healthcare Corporation Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 46. Dr.Reddy's Laboratories Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 47. Fresenious Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 48. Hikma Pharmaceuticals Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 49. Pfizer Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 50. Piramal Healthcare Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 51. Teva Pharmaceuticals Industries Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 52. Viatris Revenue Growth Rate in Medically Induced Coma Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock